Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00300495 · ClinicalTrials.gov registry record · Phase 3
Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection
A Phase 3 study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 19
- Enrollment target
NCT00300495 is a Phase 3 study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 19 participants.
The verdict
NCT00300495, a Phase 3 study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 19 participants
- Enrollment target
Study Summary
Atrial fibrillation is a very common complication of pulmonary resection. Patients who develop atrial fibrillation require additional treatment and are more likely to stay in the hospital for longer period of time increasing the costs associated with the operation. We propose a randomized controlled trial to see if oral amiodarone given for one week before surgery can prevent atrial fibrillation after pulmonary resection. We plan to evaluate the incidence of atrial fibrillation in patients who received preoperative amiodarone and compare them to the incidence of atrial fibrillation in patients who did not received preoperative amiodarone.
Interventions
- DRUG Amiodarone
- OTHER Control arm, standard care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-10-13 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00300495
The ClinicalTrials.gov registry entry for NCT00300495 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amiodarone is the first listed.
NCT00300495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00300495 about?
NCT00300495 is a clinical study titled "Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection". Atrial fibrillation is a very common complication of pulmonary resection. Patients who develop atrial fibrillation require additional treatment and are more likely to stay in the hospital for longer period of time increasing the costs associated with the operation. We propose a randomized controlled...
What is the current status of trial NCT00300495?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 19 participants. The study started on 2006-02. Estimated completion is 2009-10-13.
What interventions are being tested in trial NCT00300495?
The interventions under investigation include: Amiodarone (DRUG), Control arm, standard care (OTHER).
Who is sponsoring clinical trial NCT00300495?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.